APPLICATION
ANDA076170
TYPE
ANDA
ORIGINAL APPROVAL
2002-06-10
LATEST ACTION
2024-08-19
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
LITHIUM CARBONATEDiscontinued
LITHIUM CARBONATE 300MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2024-08-19Labeling · Supplement 8 · standardAP
2003-10-17Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.